BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31185596)

  • 1. Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
    Allegra A; Innao V; Allegra AG; Pugliese M; Di Salvo E; Ventura-Spagnolo E; Musolino C; Gangemi S
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Tienhaara A; Pelliniemi TT
    Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the role of Tregs in the progression of multiple myeloma.
    Lad D; Huang Q; Hoeppli R; Garcia R; Xu L; Levings M; Song K; Broady R
    Leuk Lymphoma; 2019 Sep; 60(9):2134-2142. PubMed ID: 30773086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.
    Bosseboeuf A; Seillier C; Mennesson N; Allain-Maillet S; Fourny M; Tallet A; Piver E; Lehours P; Mégraud F; Berthelot L; Harb J; Bigot-Corbel E; Hermouet S
    Front Immunol; 2020; 11():854. PubMed ID: 32536913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.
    D'Arena G; Rossi G; Laurenti L; Statuto T; D'Auria F; Valvano L; Simeon V; Giudice A; Innocenti I; De Feo V; Filosa R; Musto P
    J Immunol Res; 2016; 2016():9271469. PubMed ID: 27493974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma.
    Gkotzamanidou M; Christoulas D; Souliotis VL; Papatheodorou A; Dimopoulos MA; Terpos E
    Med Sci Monit; 2013 Dec; 19():1188-94. PubMed ID: 24355943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Cytometry Discovers Two Discrete Subsets of CD39
    Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S
    Front Immunol; 2019; 10():1596. PubMed ID: 31428081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
    Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spectrum of monoclonal gammopathies].
    Matuszkiewicz-Rowińska J; Wieliczko M
    Wiad Lek; 2017; 70(6 pt 2):1170-1174. PubMed ID: 29533907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Willrich MAV; Murray DL; Kyle RA
    Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.